NDC 21922-067 - Clindamycin and Benzoyl Peroxide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 21922-067
- Package NDCs from labels
- 21922-067-62, 21922-067-39, 21922-067-41, 21922-067-42
- Manufacturer
- Encube Ethicals, Inc.
- Effective date
- 2025-10-07
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Clindamycin and Benzoyl Peroxide - Encube Ethicals, Inc. | Encube Ethicals, Inc. | 2025-10-07 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 21922-067-39 | Clindamycin and Benzoyl Peroxide | 28 g in 1 BOTTLE, PUMP | GEL | 28 g | 50 mg in 1g | 1 |
| 21922-067-41 | Clindamycin and Benzoyl Peroxide | 40 g in 1 JAR | GEL | 40 g | 50 mg in 1g | 1 |
| 21922-067-42 | Clindamycin and Benzoyl Peroxide | 40 g in 1 BOTTLE, PUMP | GEL | 40 g | 50 mg in 1g | 1 |
| 21922-067-62 | Clindamycin and Benzoyl Peroxide | 20 g in 1 JAR | GEL | 20 g | 50 mg in 1g | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| DOCUZEN | SENNOSIDES 8.6MG AND DOCUSATE SODIUM 50MG | Proficient Rx LP | 92879e62-f60a-4ab4-9532-610cdd2628ee | 2023-11-01 | Warnings | F05Q2T2JA0 |
| Docusate Sodium | DOCUSATE SODIUM | A-S Medication Solutions | 5999904a-6ac8-4d9e-951c-6e64e8cd93eb | 2023-11-01 | Warnings | F05Q2T2JA0 |
| Modesa Acne Treatment | BENZOYL PEROXIDE | Zhejiang Jingwei Pharmaceutic Al Co., Ltd. | dbfe8b9e-e343-4ed5-bd81-01b27b4aa912 | 2023-10-27 | Warnings | W9WZN9A0GM |
| Acne Treatment | BENZOYL PEROXIDE | Vivier Pharma, Inc. | b4844539-bdd2-42a6-b946-6028de4f3cf1 | 2023-10-27 | Warnings | W9WZN9A0GM |
| Stool Softener Docusate Sodium | DOCUSATE SODIUM | Magno-Humphries, Inc. | a0e6ab9b-fd31-45fd-93d5-b51d705c180a | 2023-10-27 | Warnings | F05Q2T2JA0 |
| Stool Softener Docusate Sodium | DOCUSATE SODIUM | Magno-Humphries, Inc. | 9d22d642-8aed-d17e-e053-2995a90ae182 | 2023-10-27 | Warnings | F05Q2T2JA0 |
| Senna S | DOCUSATE SODIUM, SENNOSIDES | Magno-Humphries, Inc. | 9deaf264-6af0-40ba-e053-2a95a90ada0e | 2023-10-27 | Warnings | F05Q2T2JA0 |
| DOK | DOCUSATE SODIUM | MAJOR PHARMACEUTICALS | 7a92070d-98cc-662f-e053-2991aa0aa1b2 | 2023-10-23 | Warnings | F05Q2T2JA0 |
| Stool Softener | DOCUSATE SODIUM | KROGER COMPANY | a1afaa71-7e8c-5a49-e053-2a95a90a4db0 | 2023-10-23 | Warnings | F05Q2T2JA0 |
| SENNA-S | SENNA AND DOCUSATE SODIUM TABLETS, 8.6 MG AND 50 MG | HealthLife of USA LLC | 02a5299c-4b0d-47ac-9838-afd0b0fdd4a6 | 2023-10-21 | Warnings | F05Q2T2JA0 |
| Stool Softener | DOCUSATE SODIUM | Geri-Care Pharmaceutical Corp | 644d81ec-d38f-4172-a087-727b94e2fefe | 2023-10-19 | Warnings | F05Q2T2JA0 |
| Docusate Sodium | DOCUSATE SODIUM | Asclemed USA, Inc. | 30fc8c07-c26b-4bcc-a727-6e193f5727fd | 2023-10-16 | Warnings | F05Q2T2JA0 |
| Stool Softener Extra Strength | DOCUSATE SODIUM | MEIJER, INC. | e43bd2ed-17c7-4530-af72-81a7ad70069c | 2023-10-12 | Warnings | F05Q2T2JA0 |
| Stool Softener Plus Stimulant Laxative | DOCUSATE SODIUM AND SENNOSIDES | Care One (Retail Business Services, LLC.) | 9adaec97-43e3-48f2-96c8-c508b693676c | 2023-10-05 | Warnings | F05Q2T2JA0 |
| SPOT ACNE TREATMENT 0.75OZ | BENZOYL PEROXIDE | Rejoice International Corp. | 06de40a2-45bf-bf4b-e063-6294a90a586c | 2023-10-04 | Warnings | W9WZN9A0GM |
| SPOT ACNE TREATMENT 0.75OZ | BENZOYL PEROXIDE | China Ningbo Shangge Cosmetics Technology Corp. | 06e07266-6483-e7ef-e063-6294a90a9395 | 2023-10-04 | Warnings | W9WZN9A0GM |
| BHI Migraine | ACETIC ACID, ARANEUS DIADEMATUS, ASAFETIDA, BRYONIA ALBA WHOLE, TRIBASIC CALCIUM PHOSPHATE, ACTIVATED CHARCOAL, CINCHONA OFFICINALIS BARK, MARSDENIA CONDURANGO BARK, TUBOCURARINE CHLORIDE, KALMIA LATIFOLIA LEAF, LYCOPODIUM CLAVATUM SPORE, SODIUM SULFATE, PHOSPHORIC ACID, PULSATILLA VULGARIS, CLAVICEPS PURPUREA SCLEROTIUM, AND SILICON DIOXIDE | MediNatura Inc | 11cad8ba-6914-420e-bab0-4ca37d33f2e6 | 2023-09-28 | Warnings | E4GA8884NN |
| Clindamycin Phosphate | CLINDAMYCIN PHOSPHATE | Zydus Lifesciences Limited | ca60af4c-3296-4ef9-839f-9ddb34a266da | 2023-09-20 | 2676585 EH6D7113I8 | |
| ANUBISMED | HA HYALURONIC | ANUBIS COSMETICS SL | eac771e2-4c1b-3808-e053-2995a90ac5fc | 2023-09-05 | Warnings | 6DC9Q167V3 059QF0KO0R |
| AnubisMed | SPF 50 BROAD SPECTRUM PROTECTION FLUID EMULSION | ANUBIS COSMETICS SL | e99d92c4-8768-9c0a-e053-2a95a90a609e | 2023-09-05 | Warnings | 6DC9Q167V3 059QF0KO0R |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.